Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: J Diet Suppl. 2011 Mar;8(1):19–33. doi: 10.3109/19390211.2010.542233

FIGURE 6.

FIGURE 6

BRC-301 affects the expression of accessory molecules on bmDCs. BmDCs were treated with BRC-301 (0.5, 5.0, 25 μg/ml) or DMSO (0.1%) and stimulated with LPS (1 μg/ml) or unstimulated for 48 hours. The Mean Fluorescence Intensity (A) and percent positive (B) profiles were determined by FACS analysis. Results are reported as MFI ± SEM (n=3) and are representative of two independent experiments. # indicates p < .05 compared to the unstimulated control; * indicates p < .05 compared to the vehicle control.